MedPath

Center for Research in Security Prices, LLC

πŸ‡ΊπŸ‡ΈUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)

Phase 2
Completed
Conditions
Allergic Rhinitis
Interventions
Drug: ASP-1001 nasal spray
Drug: Placebo for ASP-1001
First Posted Date
2008-11-14
Last Posted Date
2013-07-10
Lead Sponsor
University of Chicago
Target Recruit Count
20
Registration Number
NCT00791102
Locations
πŸ‡ΊπŸ‡Έ

University of Chicago Medical Center, Chicago, Illinois, United States

Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women

Not Applicable
Completed
Conditions
Systemic Lupus Erythematosus
Interventions
Biological: Gardasil
First Posted Date
2008-11-06
Last Posted Date
2018-02-15
Lead Sponsor
University of Chicago
Target Recruit Count
27
Registration Number
NCT00786409
Locations
πŸ‡ΊπŸ‡Έ

University of Chicago, Chicago, Illinois, United States

MRSA Colonization and Control in the Dallas County Jail

Not Applicable
Completed
Conditions
Methicillin-resistant Staphylococcus Aureus
Skin Diseases, Infectious
Soft Tissue Infections
Interventions
Other: Chlorhexidine
Other: Water
First Posted Date
2008-11-05
Last Posted Date
2013-06-12
Lead Sponsor
University of Chicago
Target Recruit Count
4194
Registration Number
NCT00785200
Locations
πŸ‡ΊπŸ‡Έ

The Dallas County Jail, Dallas, Texas, United States

Naltrexone in the Treatment of Trichotillomania

Phase 2
Completed
Conditions
Trichotillomania
Interventions
Drug: Placebo
First Posted Date
2008-10-20
Last Posted Date
2023-02-23
Lead Sponsor
University of Chicago
Target Recruit Count
51
Registration Number
NCT00775229
Locations
πŸ‡ΊπŸ‡Έ

University of Chicago, Chicago, Illinois, United States

High-dose Cytarabine/Mitoxantrone Followed by Autotransplantation for t-MDS/t-AML

Phase 2
Completed
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Interventions
First Posted Date
2008-10-16
Last Posted Date
2014-02-11
Lead Sponsor
University of Chicago
Target Recruit Count
32
Registration Number
NCT00774046
Locations
πŸ‡ΊπŸ‡Έ

The University of Chicago, Chicago, Illinois, United States

Safety Study of Abatacept to Treat Refractory Sarcoidosis

Phase 2
Terminated
Conditions
Sarcoidosis
Interventions
First Posted Date
2008-08-22
Last Posted Date
2020-03-23
Lead Sponsor
University of Chicago
Target Recruit Count
1
Registration Number
NCT00739960
Locations
πŸ‡ΊπŸ‡Έ

The University of Chicago, Chicago, Illinois, United States

Thermal Analgesia in Newborns

Not Applicable
Completed
Conditions
Pain
Interventions
Other: warmth
Other: sucrose
First Posted Date
2008-08-22
Last Posted Date
2023-04-26
Lead Sponsor
University of Chicago
Target Recruit Count
178
Registration Number
NCT00740298
Locations
πŸ‡ΊπŸ‡Έ

The University of Chicago, Chicago, Illinois, United States

Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients

Terminated
Conditions
Cognition
Dementia
End-stage Renal Disease
First Posted Date
2008-08-22
Last Posted Date
2016-11-01
Lead Sponsor
University of Chicago
Target Recruit Count
55
Registration Number
NCT00739843
Locations
πŸ‡ΊπŸ‡Έ

University of Chicago Chronic Hemodialysis Centers, Chicago, Illinois, United States

Prospective Comparison of Cirrus Versus Stratus Ocular Coherence Tomography for Different Retinal Pathology.

Not Applicable
Completed
Conditions
Retinal Pathology
First Posted Date
2008-08-11
Last Posted Date
2013-09-05
Lead Sponsor
University of Chicago
Target Recruit Count
60
Registration Number
NCT00731458

Comparison of Two Methods of Negative Pressure Wound Therapy

Not Applicable
Completed
Conditions
Acute Wounds From Trauma
Dehiscence or Surgical Complications
Interventions
Device: Gauze suction (G-SUC)
Device: Vacuum Assisted Closure Device (VAC)
First Posted Date
2008-07-30
Last Posted Date
2015-10-19
Lead Sponsor
University of Chicago
Target Recruit Count
87
Registration Number
NCT00724750
Locations
πŸ‡ΊπŸ‡Έ

University of Chicago Medical Center, Chicago, Illinois, United States

Β© Copyright 2025. All Rights Reserved by MedPath